BGI Co-Win logo

BGI Co-Win

Asia, Guangdong, China, Shenzhen

Description

BGI Co-Win is the corporate venture capital arm of BGI and is based in Shenzhen, China.

Investor Profile

BGI Co-Win has made 3 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series E (33%)
  • Series B (33%)
  • Series Unknown (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Pharmaceutical
  • Life Science
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does BGI Co-Win frequently co-invest with?

SC
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 1
Hudson Bay Capital Management
North America, New York, United States, New York
Co-Investments: 1
DNV capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Casdin Capital
North America, New York, United States, New York
Co-Investments: 1
Bulldog Innovation Group LLC
North America, Connecticut, United States, New Haven
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
SPDB International Holdings
Asia, Hong Kong Island, Hong Kong, Hong Kong
Co-Investments: 1
Co-Investments: 1
LYFE Capital
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
3P
North America, Missouri, United States, Saint Louis
Co-Investments: 1

What are some of recent deals done by BGI Co-Win?

Aijie Boya

Suzhou, Jiangsu, China

Aijie Boya is a medical instrument and magnetic solid-phase material company.

MedicalMedical Device
Series UnknownFeb 12, 2025
Amount Raised: $13,682,698
CANbridge Pharmaceuticals

Beijing, Beijing, China

CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .

BiotechnologyHealth CarePharmaceutical
Series EDec 1, 2020
Amount Raised: $43,000,000
MGI Tech

Shenzhen, Guangdong, China

MGI Tech focuses on developing and promoting advanced life science tools for future healthcare.

BiotechnologyHealth CareLife ScienceMedical
Series BMay 28, 2020
Amount Raised: $1,000,000,000